Question explored with the scientific record
Started from a private conversation ↓
What does topical use mean
Topical use means applying DMSO directly to the skin, not swallowing it or injecting it. The evidence shows DMSO is a real skin-penetration enhancer with measurable anti-inflammatory effects, but the data come mostly from animal studies and old trials.
The term is straightforward. Topical application means putting DMSO on the skin so it passes through the outer layer and into the tissues below. This is how DMSO has been studied most: as a carrier that pulls other drugs through the skin, and as an anti-inflammatory agent on its own.
The 2024 narrative review confirms DMSO disorganizes skin lipids in a concentration-dependent way [2]. At 50% concentration, model skin barriers leaked 60% of their contents [2]. That is not a side effect, it is the mechanism. DMSO opens the skin barrier so that whatever is dissolved in it goes deeper. That is why it works as a penetration enhancer, and it is why people using it feel a warming or stinging sensation.
The anti-inflammatory effect is also real but modest. In mouse models of arthritis and melanoma, topical DMSO at 0.5% to 2% reduced proinflammatory cytokines and white blood cell levels [2]. In diabetic mice, a low concentration (5 mM) accelerated wound healing, while a higher concentration (20 mM) delayed it [2]. That dose-response pattern matters: topical DMSO is not a simple "more is better" substance.
The harms are mostly local and dose-dependent. The garlic breath halitosis is the most reported systemic effect, coming from DMSO being metabolized to dimethyl sulfide in the blood. In a 1960s cohort using 90% DMSO, halitosis appeared in 5 of 6 inpatients and 9 of 10 outpatients [2]. In a modern cohort using 45.5% high-purity DMSO, only 12 of 1,243 patients reported it [2]. That suggests purity and concentration matter a great deal for tolerability.
What this evidence does not answer: how much DMSO actually reaches the bloodstream from the skin, what happens with repeated daily use over months, and whether the skin barrier changes permanently under regular DMSO exposure. The 1998 rabbit skin flap study found DMSO alone improved flap survival to 76% versus 71% controls [1], but animal data does not replace human long-term safety data.
| Route | Key effect | Main side effect | Evidence quality |
|---|---|---|---|
| Topical DMSO alone | Modest anti-inflammatory | Skin irritation, garlic breath | Moderate (old trial + animal data) |
| Topical DMSO + drug | Penetration enhancer | Drug gets deeper, skin irritation | Good for diclofenac, weak for others |
| High concentration (50%+) | Strong barrier disruption | 60% lipid leakage in models, burning | Low (mostly in vitro) |
My call: topical DMSO has real effects as a skin-penetration enhancer and a mild anti-inflammatory, best evidence is for the 45.5% high-purity formulation used with diclofenac. Long-term safety data is absent, and high concentrations cause predictable skin irritation and halitosis. Confidence: moderate.
Sources used 2
-
Pharmacological enhancement of cutaneous flap survival with topical dimethyl sulphoxide and hydrogen peroxide
This study investigates the effects of topical application of hydrogen peroxide and dimethyl sulfoxide on the survival of random skin flaps in a rabbit model, finding that the combination significantly improves flap viability compared to controls.
DOI: 10.1054/bjps.1998.0063 -
Dimethyl sulfoxide in topical pharmaceutical drug development: A fresh perspective
A narrative review proposes that high-purity (>99.99%) DMSO is an effective, underused topical penetration enhancer with anti-inflammatory and analgesic activity, and that higher purity may reduce the halitosis historically associated with topical DMSO.
DOI: 10.66617/001c.120609